OMED

OncoMed Pharmaceuticals, Inc.
OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

53 hedge funds and large institutions have $66.3M invested in OncoMed Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$16.2M
2
+$6M
3
+$4.14M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$4.12M
5
Primecap Management
Primecap Management
California
+$3.75M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$423K
27
$405K
28
$402K
29
$358K
30
$207K
31
$206K
32
$188K
33
$185K
34
$184K
35
$157K
36
$154K
37
$123K
38
$119K
39
$104K
40
$100K
41
$91K
42
$83K
43
$80K
44
$77K
45
$68K
46
$32K
47
$31K
48
$17.9K
49
$17K
50
$4K
1
2
3